Literature DB >> 32968238

The effect of early puberty suppression on treatment options and outcomes in transgender patients.

Leonidas Panagiotakopoulos1, Veenod Chulani2, Atsuko Koyama3, Krista Childress4, Michelle Forcier5,6, Gwen Grimsby7, Katherine Greenberg8.   

Abstract

In the past 10-15 years, paediatric transgender care has emerged at the forefront of several general practice and subspecialty guidelines and is the topic of continuing medical education for various medical disciplines. Providers in specialties ranging from family medicine, paediatrics and adolescent medicine to endocrinology, gynaecology and urology are caring for transgender patients in increasing numbers. Current and evolving national and international best practice guidelines recommend offering a halt of endogenous puberty for patients with early gender dysphoria, in whom impending puberty is unacceptable for their psychosocial health and wellness. Pubertal blockade has implications for fertility preservation, transgender surgical care and psychosocial health, all of which must be considered and discussed with the patient and their family and/or legal guardian before initiation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32968238     DOI: 10.1038/s41585-020-0372-2

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  2 in total

1.  Transgender Youth Experiences with Implantable GnRH Agonists for Puberty Suppression.

Authors:  Brianna J Hobson; Elle Lett; Linda A Hawkins; Robert A Swendiman; Michael L Nance; Nadia L Dowshen
Journal:  Transgend Health       Date:  2022-08-01

2.  Bell v Tavistock and Portman NHS Foundation Trust [2020] EWHC 3274: Weighing current knowledge and uncertainties in decisions about gender-related treatment for transgender adolescents.

Authors:  Annelou L C de Vries; Christina Richards; Amy C Tishelman; Joz Motmans; Sabine E Hannema; Jamison Green; Stephen M Rosenthal
Journal:  Int J Transgend Health       Date:  2021-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.